The Global Osteoarthritis Pain Drugs Market Report is highly intended to offer robust acumen considering Osteoarthritis Pain Drugs Market industry to aid a market contender with insightful analysis for Osteoarthritis Pain Drugs Market size, share, competitive scenario, segments, sub-segments, and dominant industry competitors. The report focuses on the historic and current situation of the market to provide valuable forecast analysis based on sales revenue, global demand, and growth rate of the market.
The global Osteoarthritis Pain Drugs market is valued at 8295.4 million US$ in 2020 is expected to reach 12300 million US$ by the end of 2026, growing at a CAGR of 5.7% during 2021-2026.
Market Key Players
Johnson & Johnson, Pfizer, GlaxoSmithKline, Mylan, Lilly, Sanofi, Abbott Laboratories, Bayer, Almatica Pharma, TEVA, Iroko Pharmaceuticals.
(Exclusive Offer: Flat 30% discount on this report)
Get a Sample Copy of the Report
The main role of osteoarthritis pain drugs is to relieve pain, and cannot slow the progress of osteoarthritis, osteoarthritis in the use of two kinds of painkillers:
Painkillers only: Only a simple analgesic effect, but no anti-inflammatory function, such as acetaminophen, tramadol. Acetaminophen side effects, but the analgesic effect is relatively weak, mainly for mild to moderate pain; tramadol analgesic effect is strong, but also side effects are larger, mainly gastrointestinal side effects such as nausea, vomiting and so on.
NSAIDs: With both anti-inflammatory and analgesic effect, suitable for inflammatory pain, for the acute phase of osteoarthritis, joint swelling of the patients to relieve symptoms better. These drugs may lead to nausea, vomiting and other gastrointestinal discomfort, but also increase the risk of gastrointestinal bleeding, so patients with gastro duodenal ulcer in the application of these drugs should consult a digestive physician, plus gastric mucosal protection Drugs or antacid drugs.
Segment by Type, the Osteoarthritis Pain Drugs market is segmented into
Segment by Application
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Medicines for Osteoarthritis Pain are available as pills, syrups, creams or lotions, or they are injected into a joint.
Osteoarthritis, the most common type of arthritis, is a leading cause of disability. It is a chronic, progressive degenerative joint disease, which is characterized by gradual destruction of the articular cartilage, hypertrophy of the bone margins, and a series of biochemical and morphological changes in the synovial membrane and joint capsule. This results in pain and loss of movement.
Important Features that are under offering and key highlights of the report:
Detailed overview of Osteoarthritis Pain Drugs market
Changing market dynamics of the industry
In-depth market segmentation by Type, Application etc.
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape of Osteoarthritis Pain Drugs market
Strategies of key players and product offerings
Potential and niche segments/regions exhibiting promising growth
A neutral perspective towards Osteoarthritis Pain Drugs market performance
Must-have information for market players to sustain and enhance their market footprint
We Also Offer Customization on report based on specific client Requirement:
Free country Level analysis for any 5 countries of your choice.
Free Competitive analysis of any 5 key market players.
Free 40 analyst hours to cover any other data point.
Media Contact Us:
Irfan Tamboli (Head of Sales) – Market Insights Reports
Phone: + 1704 266 3234 | +91-750-707-8687
firstname.lastname@example.org | email@example.com